Skip to content

Glucotrack, Inc.: 10-Q filed 2014-05-13

What Glucotrack, Inc. reported in its quarterly report filed 2014-05-13 (fiscal Q1 2014): 20 published measures, 74 facts as tagged in accession 0001178913-14-001619.

This filing

Form
10-Q (quarterly report)
Filed
2014-05-13
Fiscal period
fiscal Q1 2014
Accession
0001178913-14-001619 on SEC EDGAR

Values are as tagged in this filing. A later filing can restate them; each measure links to its history page, which shows the latest-filed value per period. All Glucotrack, Inc. filings.

Reported measures

Total assets

Resources recognized on the balance sheet. Book assets are not the market value of the business.

PeriodValueUnitDays
At 2014-03-311,982,338USD
At 2013-12-312,756,205USD

Total liabilities

Recognized obligations at the reporting date. The definition and scope differ from interest-bearing debt.

PeriodValueUnitDays
At 2014-03-319,496,931USD
At 2013-12-319,456,778USD

Stockholders equity

The reported residual interest after liabilities. It is an accounting amount, not market capitalization.

PeriodValueUnitDays
At 2014-03-31-11,871,250USD
At 2013-12-31-11,063,118USD
At 2012-12-31-503,069USD
At 2011-12-31968,239USD
At 2010-12-31598,139USD
At 2009-12-31-775,742USD
At 2008-12-3149,750USD
At 2007-12-31542,217USD
At 2006-12-311,776,235USD
At 2005-12-31-270,063USD
At 2004-12-31-487,627USD
At 2003-12-31-388,181USD
At 2002-12-31-22,856USD

Cash and cash equivalents

Cash and qualifying short-term liquid investments under the filer’s accounting policy. Restricted cash and longer-term investments may be reported separately.

PeriodValueUnitDays
At 2014-03-311,617,121USD
At 2013-12-312,385,911USD
At 2013-03-315,325,340USD
At 2012-12-31543,411USD
At 2011-12-311,896,504USD

Net income or loss

Reported profit or loss for the period. Check the filing for attribution, exceptional items and discontinued operations before comparing companies.

PeriodValueUnitDays
2014-01-01 to 2014-03-31-736,919USD90
2001-09-30 to 2014-03-31-25,823,598USD4566
2013-01-01 to 2013-12-31-9,796,853USD365
2013-01-01 to 2013-03-31-1,343,595USD90
2012-01-01 to 2012-12-31-2,772,307USD366
2011-01-01 to 2011-12-31-2,364,339USD365
2010-01-01 to 2010-12-31-2,788,446USD365
2009-01-01 to 2009-12-31-1,202,296USD365
2008-01-01 to 2008-12-31-1,528,981USD366
2007-01-01 to 2007-12-31-1,593,205USD365
2006-01-01 to 2006-12-31-1,282,842USD365
2005-01-01 to 2005-12-31-1,055,594USD365
2004-01-01 to 2004-12-31-288,233USD366
2003-01-01 to 2003-12-31-350,290USD365
2001-09-30 to 2002-12-31-63,293USD458

Capital expenditure payments

Cash payments to acquire property, plant and equipment. This taxonomy concept does not capture every form of investment or acquisition.

PeriodValueUnitDays
2014-01-01 to 2014-03-318,854USD90
2001-09-30 to 2014-03-31293,226USD4566
2013-01-01 to 2013-03-31786USD90

Retained earnings or deficit

Accumulated undistributed earnings or deficit at the reporting date. This balance is not cash available for distribution.

PeriodValueUnitDays
At 2014-03-31-26,482,783USD
At 2013-12-31-25,653,190USD

Net property, plant and equipment

Carrying amount of property, plant and equipment after accumulated depreciation, depletion and amortization. It is not replacement cost or market value.

PeriodValueUnitDays
At 2014-03-31107,477USD
At 2013-12-31107,209USD

Share-based compensation expense

Reported noncash expense for share-based payment arrangements. Noncash treatment does not mean the awards have no economic cost to shareholders.

PeriodValueUnitDays
2014-01-01 to 2014-03-3114,701USD90
2001-09-30 to 2014-03-311,630,745USD4566
2013-01-01 to 2013-03-316,151USD90

Operating income or loss

Operating revenue less operating expenses for the reporting period. It excludes items outside the reported operating result and is not free cash flow.

PeriodValueUnitDays
2014-01-01 to 2014-03-31-887,186USD90
2001-09-30 to 2014-03-31-17,405,214USD4566
2013-01-01 to 2013-03-31-687,824USD90

Current assets

Assets classified as current under the normal operating cycle or one-year boundary. Not all current assets can be converted immediately into cash.

PeriodValueUnitDays
At 2014-03-311,705,609USD
At 2013-12-312,478,963USD

Current liabilities

Obligations classified as current under the operating-cycle or one-year boundary. The balance includes more than short-term borrowing.

PeriodValueUnitDays
At 2014-03-31505,919USD
At 2013-12-31310,907USD

Current accounts payable

Current amounts owed to suppliers for goods and services received. This is one component of current liabilities, not all accrued obligations.

PeriodValueUnitDays
At 2014-03-31135,561USD
At 2013-12-3149,787USD

Selling, general and administrative expense

Selling and general administrative costs reported under this concept. It is an expense category, not a substitute for total operating expenses.

PeriodValueUnitDays
2014-01-01 to 2014-03-31436,102USD90
2001-09-30 to 2014-03-314,491,884USD4566
2013-01-01 to 2013-03-31183,579USD90

Research and development expense

Research and development costs recognized as expense. Capitalization policies and acquired projects can make this differ from total cash invested in development.

PeriodValueUnitDays
2014-01-01 to 2014-03-31451,084USD90
2001-09-30 to 2014-03-3112,914,242USD4566
2013-01-01 to 2013-03-31504,245USD90

Common shares outstanding

Common shares outstanding at the reporting date. This point-in-time count differs from the weighted-average shares used for earnings per share and can exclude other share classes.

PeriodValueUnitDays
At 2014-03-315,304,072shares
At 2013-12-315,301,693shares

Accumulated other comprehensive income or loss

Cumulative other comprehensive items after tax, such as translation and unrealized hedging or securities effects. These amounts have not passed through net income.

PeriodValueUnitDays
At 2014-03-3153,574USD
At 2013-12-3152,702USD

Comprehensive income or loss

Net income plus other comprehensive income after tax. It includes unrealized items that net income excludes and is not a cash measure.

PeriodValueUnitDays
2014-01-01 to 2014-03-31-737,791USD90
2001-09-30 to 2014-03-31-25,877,171USD4566
2013-01-01 to 2013-03-31-1,349,948USD90

Net income available to common stockholders

Net income after preferred dividends and similar adjustments, the numerator for basic earnings per share. It can be lower than reported net income.

PeriodValueUnitDays
2014-01-01 to 2014-03-31-829,593USD90
2013-01-01 to 2013-03-31-1,359,345USD90

Depreciation expense

Depreciation recognized for the period under this concept. It is a noncash allocation of asset cost and may exclude amortization and depletion reported elsewhere.

PeriodValueUnitDays
2014-01-01 to 2014-03-318,096USD90
2001-09-30 to 2014-03-31199,813USD4566
2013-01-01 to 2013-03-317,027USD90

Inspect the source

Entity
Glucotrack, Inc. / CIK 0001506983
Captured
2026-09-20T09:12:36.213Z
SEC response SHA-256
91f527d0410e6f1b0a32a3b43c134ea7cd7d1bc7628a5c4dcf15089cf98e8a12

Current SEC company facts · Download the original response snapshot (gzip) · Download the selected JSON

Every published concept a filing tagged, with the periods it covered, as reported in that filing at capture time. Forms 10-K, 10-K/A, 10-Q, 10-Q/A, 20-F, 20-F/A, 40-F, 40-F/A. A filing page needs at least 8 published concepts. Later filings can restate these values; the company history pages show the latest-filed value per period.

Public company accounting reference, not market prices, returns, an investment recommendation, or ALPHAC performance. Validate a separately constructed return series with the validation API; accounting values are not returns.

Use this in research

A financial period ends before its results become public. Use the filing date as a minimum availability boundary, inspect amendments, and retain the original filing vintage when testing historical signals. This latest-filed selection can contain information unavailable at the time.

These pages do not supply prices, total-return histories, corporate-action adjustments or a tradable universe. Build those inputs separately before evaluating a strategy. A profitable backtest can still reflect selection bias or costs that were left out.

Research methodology · Execution and cost assumptions · Check backtest overfitting

Build with the open-source tools

Use these accounting records as inspectable inputs. When you have constructed a return series, the validation tools can help test its statistical evidence and preserve the result with its limitations.

Read the published dataset with Python
import json
from urllib.request import urlopen

with urlopen("https://canlicapital.com/company-data/0001506983.json") as response:
    record = json.load(response)
print(record["fetched_at"])
print(record["policy"])
for concept in record["concepts"]:
    print(concept["tag"], next(iter(concept["observations"])))